All hematologists of the country were invited. As part of the celebration, a day-long scientific seminar was organized and speakers were Dr. Nasrin Akhter, Dr. Menoti Paul Mukti, Dr. Mujahida Rahman, Dr. Mafruha Akter, Dr. Tasneem Ara, Dr. Huque Mahfuz, Dr. Akhil Ranjon Biswas and Dr. Abdullah Az Zubayer Khan. Dr. Bimalangshu Dey from Boston and Dr. Amin Islam from UK also participated LIVE in the session through online. Dr. Abu Jafar Mohammed Saleh, Coordinator and Senior Consultant of Hematology and Stem Cell Transplant Department of Evercare Hospital Dhaka (EHD) and Evercare Hospital Chattogram (EHC) chaired the scientific session and shared his future plan to make bone marrow transplant available for all patients in Bangladesh. Dr. Abu Jafar Mohammed Saleh also mentioned that there is no need to go abroad for blood cancer treatment as it is already available in our own country.
Brig. Gen. (Rtd.) AKM Mustafa Abedin, President – Hematology Society of Bangladesh; Prof. Md. Salahuddin Shah, Chairman, Department of Hematology BSMMU; Prof. Mohiuddin Ahmed Khan, Ex-HOD DMCH; Prof. M. A. Aziz, BSMMU were present along with other prominent hematologists. Dr. Arif Mahmud, Director Medical Services and other high officials of Evercare Hospital Dhaka were also present in the scientific session.
About the Evercare Group
The Evercare Group believes access to healthcare is a fundamental right and invests in emerging markets to bring private, quality driven healthcare to meet the needs of local people. Evercare has responded to a global challenge to ensure well-being at all ages is provided to those living in emerging markets as a pillar to support sustainable economic development. With this the Group is leading the way in transforming the traditional healthcare model through its integrated cross-continents platform, its impact driven model and quality driven hospitals.
The Evercare Group operates as an integrated healthcare delivery platform in emerging markets across Africa and South Asia, including India, Pakistan, Bangladesh, Kenya and Nigeria. The Group’s portfolio includes 30 hospitals with 3445 beds, 16 clinics, 82 diagnostics centres and two brownfield assets spread over 6 countries. Evercare is proud to be the most diverse healthcare group in the countries it operates in with 11,000 caregivers working together to develop a systemic healthcare change in emerging markets.
Evercare is wholly owned by the Evercare Health Funds, a US $1bn emerging markets healthcare fund managed by The Rise Funds, the impact investment platform of global alternative asset manager TPG. The Evercare Health Fund is comprised of the world’s leading development finance institutions and other impact investors around the world.